These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1184537)

  • 1. Hepatic injury due to ethionamide (1314-TH) and prothionamide (1321-TH).
    Gupta DK; Mital OP; Agarwala MC
    J Assoc Physicians India; 1975 Feb; 23(2):147-51. PubMed ID: 1184537
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in serum transaminase due to prothionamide.
    Somner AR; Brace AA
    Tubercle; 1967 Jun; 48(2):137-43. PubMed ID: 6048656
    [No Abstract]   [Full Text] [Related]  

  • 3. Side effects and toxicity of ethionamide and prothionamide.
    Tala E; Tevola K
    Ann Clin Res; 1969 May; 1(1):32-5. PubMed ID: 5350768
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study on hepatic disturbance during ethionamide or prothionamide treatment. Comparative study by using the same type of preparation of both drugs].
    Osato T
    Kekkaku; 1971 Sep; 46(9):345-9. PubMed ID: 5122003
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatotoxicity of combined therapy with rifampicin and daily prothionamide for leprosy.
    Ji BH; Chen JK; Wang CM; Xia GA
    Lepr Rev; 1984 Sep; 55(3):283-9. PubMed ID: 6492989
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampin drug interactions.
    Holdiness MR
    Arch Intern Med; 1987 Oct; 147(10):1856. PubMed ID: 3662720
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis and multi-drug therapy in leprosy with special reference to prothionamide.
    Kar HK; Balakrishnan S; Vasantha Kumar G; Sirumban P; Roy RG
    Indian J Lepr; 1985; 57(1):78-89. PubMed ID: 3839828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of therapeutic efficacy and toxicity of ethionamide and prothionamide in Indian patients.
    Gupta DK; Mital OP; Agarwal MC; Kansal HM; Nath S
    J Indian Med Assoc; 1977 Jan; 68(2):25-9. PubMed ID: 326974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electron microscopic observation of prothionamide-induced hepatitis].
    Takahama T; Koyama W; Tomita S; Doi N; Shih A
    Kumamoto Igakkai Zasshi; 1971 Nov; 45(11):1081-8. PubMed ID: 5172321
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatotoxicity of the daily combination of 5 mg/kg prothionamide + 10 mg/kg rifampin.
    Cartel JL; Naudillon Y; Artus JC; Grosset JH
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):15-8. PubMed ID: 3998559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.
    Fox W; Robinson DK; Tall R; Kent PW; Macfadyen DM
    Tubercle; 1969 Jun; 50(2):125-43. PubMed ID: 4894707
    [No Abstract]   [Full Text] [Related]  

  • 12. Acceptability of thioamides. II. Prothionamide.
    Gupta DK
    J Postgrad Med; 1977 Oct; 23(4):181-5. PubMed ID: 615265
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of therapeutic effect and side actions of 1314 TH and 1321 TH in the initial therapy of tuberculosis].
    Sunahara S; Nagasawa S
    Saishin Igaku; 1969 Apr; 24(4):922-7. PubMed ID: 5807960
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
    Fajardo TT; Guinto RS; Cellona RV; Abalos RM; Dela Cruz EC; Gelber RH
    Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxic liver change caused by ethionamide].
    Kuntz E; Liehr H; Pfingst W
    Dtsch Med Wochenschr; 1967 Sep; 92(38):1718-22. PubMed ID: 6054330
    [No Abstract]   [Full Text] [Related]  

  • 16. [Astheno-depressive syndrome in patients with pulmonary tuberculosis after administration of protionamide].
    Bilyk MA; Dubchik GKh
    Klin Med (Mosk); 1976 Dec; 54(12):111-2. PubMed ID: 1011739
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the blood levels and urinary excretion of ethionamide and prothionamide in man.
    Jenner PJ; Ellard GA; Gruer PJ; Aber VR
    J Antimicrob Chemother; 1984 Mar; 13(3):267-77. PubMed ID: 6725176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative characteristics of the effectiveness and tolerance of ethionamide and prothionamide in the clinical treatment of pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Probl Tuberk; 1973; 51(10):37-40. PubMed ID: 4784035
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Shmelev NA; Korotaev GA; Poleshchuk AK; Utkin VV; Golitsyna LV
    Probl Tuberk; 1969; 47(1):27-33. PubMed ID: 5380204
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of ethionamide (TH-1314) and prothionamide (TH-1321) on gastric juice acidity.
    Gupta DK; Agarwal MC; Mittal OP
    Indian J Chest Dis; 1974 Jul; 16(3):163-70. PubMed ID: 4418691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.